FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
Commonly reported side effects included fever, runny nose, congestion and sore throat. “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
FLUMIST ® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...